Larvol Delta - Disproportionality-analysis-of-pyoderma-gangrenosum-reporting-to-the-FDA-Adverse-Event-Reporting-System-in-association-with-antirheumatic-biologics

Bimzelx (bimekizumab-bkzx) - UCB

Siliq (brodalumab) - Bausch Health

http://www.ncbi.nlm.nih.gov/pubmed/42310248

Richard H Woods

Jun 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next